Cancer Diagnostics
The latest news about Cancer Diagnostics: headlines, AI summaries and the full story from every source.
- DataMEDS Acquires Helomics for $1.5 Million, Expanding into Cancer Diagnostics
- Proteotype Launches €3 Million European Study to Expand Multi-Cancer Detection Validation
- Tempus Acquires Personalis for $1.5 Billion in Bid to Control Cancer-Test Market
- Tempus Agrees to Acquire Cancer Test Maker Personalis for $1.5 Billion
- VolitionRx Submits Manuscript for Nu.Q® Vet Feline Cancer Test in Cats